Clinical trial
Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of…
NCT00188240 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00188240 |
|---|---|
| Title | Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy |
| Official title | Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Anti-Viral Therapy |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Hepatitis C, Hepatitis B |
| Intervention type | Drug |
| Interventions | Pegasys, Copegus. |
| Enrollment | 200 |
| Start date | Aug 1, 2003 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 29, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: